Korea Targets Biologics, Devices, Health Care Among Economic Growth Projects For Next Decade
This article was originally published in PharmAsia News
Executive Summary
SEOUL - South Korean President Lee Myung-bak named "17 new growth engines" at a science and technology council meeting at his office in Seoul Jan. 13. Expected to spearhead the country's economic growth for the next 10 years, of those 17 economic growth engines, the Korean government targeted biologics, medical devices and global health care among the national priorities
You may also be interested in...
South Korea Launches Second Pharma Development Fund
South Korea’s Ministry of Health and Welfare is launching its second ‘Global Pharma Industry Development Fund’ worth KRW135 billion ($124 million) to help small and mid-sized local firms with cooperative technology development, deals with foreign venture firms, sales networks and production facilities in foreign countries, and global clinical trials.
Korea Regulatory Shake Up: President-elect To Upgrade FDA Status, Downgrade Health Ministry
The proposal would expand KFDA’s regulatory oversight powers, despite pushback from the health ministry.
Drug Price Cuts Could Be Option For New Korean President
Whoever wins the Dec. 19 presidential election in Korea is expected to consider another round of drug prices cuts as a way to pay for expanded health care coverage.